Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Hepatocellular 6Neoplasm Metastasis 5Melanoma 3Cholangiocarcinoma 3Breast Neoplasms 3Sarcoma 2Osteosarcoma 2Liver Neoplasms 2Kidney Neoplasms 2Colorectal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Wilms Tumor 1Urinary Bladder Neoplasms 1Unresectable Solid Tumors 1Solid Tumor, Adult 1Skin Neoplasms 1Sarcoma, Ewing 1Rhabdomyosarcoma 1Retinoblastoma 1Rectal Neoplasms 1Pancreatic Adenocarcinoma Locally Advanced 1Neuroblastoma 1Lung Neoplasms 1Liver Metastasis 1High-Burden Metastatic Solid Tumors 1Hepatoblastoma 1Gastric Cancer Metastatic to Liver 1Diabetes Mellitus, Insulin-Dependent, 12 1Desmoid Tumors 1Colonic Neoplasms 1

Interventions

pembrolizumab 31Gemcitabine 26Nivolumab 20atezolizumab 16Cisplatin 15avelumab 14Carboplatin 12Docetaxel 10enfortumab vedotin 8Magnetic Resonance Spectroscopy 8durvalumab 7Specimen Handling 7Paclitaxel 7Ipilimumab 6toripalimab 5pemigatinib 5cabozantinib 5vinflunine 4sacituzumab govitecan 4Taxes 4Pemetrexed 4tislelizumab 3cabazitaxel 3Standard of Care 3Mitomycin 3Injections 3Everolimus 3Albumin-Bound Paclitaxel 3sapanisertib 2olaparib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Carcinoma, Transitional Cell × Cryosurgery × Clear all
NCT04701918 2026-01-22

Cryoablation With Pembrolizumab Or Avelumab In Urothelial Carcinoma

Massachusetts General Hospital

Phase 2 Completed
9 enrolled
Genitourinary

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡